Skip to main content



Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Poster Icons
Spotlight Poster Icon
Spotlight Poster Icon
Spotlight Winner
Spotlight Winner

  • Friday, Aug 26th
    6:00 PM - 6:15 PM CEST
    Patient Groups in Rheumatoid Arthritis Identified by Deep Learning Respond Differently to Biologic or Targeted Synthetic Disease Modifying Antirheumatic Drugs
    Location: C1M1
    Presenting Author: Theresa Burkard, PhD – ETH Zurich
    Co-Author: Maria Kalweit – University of Freiburg
    Co-Author: Andrea Burden – Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences
    Co-Author: Thomas Hügle – University Hospital Lausanne (CHUV)
    Biologics/Biosimilars
  • Saturday, Aug 27th
    1:30 PM - 1:35 PM CEST
    Predictors of Effectiveness of First-line Biologic Disease Modifying Antirheumatic Drug(s) (bDMARD) or Targeted Synthetic DMARD (tsDMARD) Treatment with a Tumor Necrosis Factor Inhibitor in Patients with Rheumatoid Arthritis
    Location: C1M2
    Presenting Author: Alexander Liede, PhD – AbbVie
    Co-Author: Whitney Krueger, PhD – AbbVie
    Co-Author: Linyan Li – GNS Healthcare
    Co-Author: Yuhang Liu – GNS Healthcare
    Co-Author: Yi Pan – GNS Healthcare
    Co-Author: Michelle Brauer – GNS Healthcare
    Co-Author: Seoyoung Kim, MD, DSc – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
    Co-Author: Earl Steinberg – GNS Healthcare
    Biologics/Biosimilars
  • Saturday, Aug 27th
    1:35 PM - 1:40 PM CEST
    Effect Modification of Biologic Survival by Patient Characteristics: A Step Towards Precision Medicine in the Treatment of Psoriasis
    Location: C1M2
    Presenting Author: Zenas Yiu – The University of Manchester
    Co-Author: Gabrielle Becher – West Glasgow Ambulatory Care Hospital, Glasgow, UK
    Co-Author: Brian Kirby – Charles Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland and School of Health Sciences and Charles Institute, University College Dublin, Dublin, Ireland.
    Co-Author: Philip Laws – Department of Dermatology, The Leeds Teaching Hospitals NHS Trust, Leeds, UK.
    Co-Author: Nick Reynolds – Institute of Translational and Clinical Medicine, Newcastle University Medical School and Department of Dermatology, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
    Co-Author: Catherine Smith – St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom.
    Co-Author: Richard Warren – Centre for Dermatology Research, University of Manchester, Manchester, UK.
    Co-Author: Christopher Griffiths – Centre for Dermatology Research, University of Manchester, Manchester, UK.
    Biologics/Biosimilars
  • Saturday, Aug 27th
    1:40 PM - 1:45 PM CEST
    Application of a Systems Biology Approach to Address Confounding by Indication for Immune-mediated Disorders in Spontaneous Reports Data: A Case Study of Vedolizumab-associated Pancreatitis in Inflammatory Bowel Disease
    Location: C1M2
    Presenting Author: Jodie Hillen, MClinE, PhD, BPharm – University of South Australia
    Co-Author: Katherine Duszynski, BSc – University of South Australia
    Co-Author: Ty Stanford – University of South Australia
    Co-Author: Michael Ward – University of South Australia
    Co-Author: Elizabeth Roughead – University of South Australia
    Co-Author: Lisa Kalisch – University of South Australia
    Co-Author: Nicole Pratt, FISPE – University of South Australia
    Biologics/Biosimilars
  • Saturday, Aug 27th
    1:45 PM - 1:50 PM CEST
    Discontinuation of Infliximab Treatment in IBD Patients: A Comparison Between Patients Who Retransitioned to Originator and Those Who Remained on Biosimilar
    Location: C1M2
    Presenting Author: Rosanne Meijboom – Stichting Apotheek der Haarlemse Ziekenhuizen
    Co-Author: Helga Gardarsdottir, PhD, FISPE – University of Utrecht
    Co-Author: Matthijs Becker, n/a – Pharmacy Foundation of Haarlem Hospitals, Haarlem, the Netherlands
    Co-Author: Kris Movig – Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, the Netherlands
    Co-Author: Johan Kuijvenhoven – Department of Gastroenterology and Hepatology, Spaarne Gasthuis, Haarlem and Hoofddorp, The Netherlands
    Co-Author: Toine Egberts – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands
    Co-Author: Thijs J. Giezen, PhD – Stichting Apotheek der Haarlemse Ziekenhuizen
    Biologics/Biosimilars